WP
ABBV icon

Woodline Partners’s AbbVie ABBV Stock Holding History

Woodline Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.3M Buy
346,177
+149,913
+76% +$33.3M 0.28% 73
2025
Q4 		$44.8M Sell
196,264
-37,197
-16% -$8.47M 0.17% 155
2025
Q3 		$54.1M Sell
233,461
-95,888
-29% -$19.5M 0.25% 97
2025
Q2 		$61.1M Sell
329,349
-298,745
-48% -$55.5M 0.32% 72
2025
Q1 		$132M Buy
628,094
+23,036
+4% +$4.48M 0.86% 9
2024
Q4 		$108M Sell
605,058
-203,678
-25% -$37.4M 0.73% 12
2024
Q3 		$160M Buy
808,736
+58,414
+8% +$10.9M 1.35% 3
2024
Q2 		$129M Buy
750,322
+111,929
+18% +$18.5M 1.23% 5
2024
Q1 		$116M Sell
638,393
-636,304
-50% -$110M 1.07% 12
2023
Q4 		$198M Buy
1,274,697
+31,351
+3% +$4.57M 2.15% 1
2023
Q3 		$185M Buy
1,243,346
+822,491
+195% +$121M 2.17% 2
2023
Q2 		$56.7M Sell
420,855
-59,150
-12% -$8.67M 0.67% 33
2023
Q1 		$76.5M Buy
480,005
+30,431
+7% +$4.65M 1.04% 13
2022
Q4 		$72.7M Buy
449,574
+262,486
+140% +$40.2M 0.97% 12
2022
Q3 		$25.1M Buy
+187,088
New +$26.8M 0.35% 78
2022
Q1 		– Sell
-1,070,201
Closed -$145M – 710
2021
Q4 		$145M Buy
1,070,201
+289,792
+37% +$34.2M 2.08% 3
2021
Q3 		$84.2M Buy
780,409
+169,879
+28% +$19.4M 1.37% 6
2021
Q2 		$68.8M Buy
610,530
+469,295
+332% +$52.9M 1.28% 11
2021
Q1 		$15.3M Buy
+141,235
New +$15.1M 0.34% 81

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Woodline Partners's ABBV Position: Q1 2026 in Review

Woodline Partners increased its AbbVie (ABBV) stake by 76% in Q1 2026, buying an estimated $33.3M and bringing the position to 346,177 shares worth $75.3M. The position accounts for 0.28% of the portfolio, ranked #73.

Woodline Partners first reported a position in ABBV in Q1 2021 and has held it in 19 quarters since. The position peaked at $198M in Q4 2023. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Woodline Partners held 346,177 shares of AbbVie worth $75.3M as of Q1 2026.
  • Woodline Partners bought 149,913 AbbVie shares in Q1 2026, an estimated $33.3M.
  • AbbVie made up 0.28% of Woodline Partners's portfolio in Q1 2026, its #73 holding.
  • Woodline Partners first reported a position in AbbVie in Q1 2021 and has held it in 19 quarters since.
  • Woodline Partners's AbbVie position peaked at $198M in Q4 2023.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.